advertisement
Frontiers in pharmacology 12
Showing records 1 to 12 | Display all abstracts in Frontiers in pharmacology106370 Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Brandt AL
Frontiers in pharmacology 2022; 13: 919605
106221 Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
Zhou L
Frontiers in pharmacology 2022; 13: 1015338
105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Huang L; Ye Q
Frontiers in pharmacology 2022; 13: 990401
106221 Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
Zhan W
Frontiers in pharmacology 2022; 13: 1015338
106370 Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Garai S
Frontiers in pharmacology 2022; 13: 919605
105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Lan C
Frontiers in pharmacology 2022; 13: 990401
106221 Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
Wei X
Frontiers in pharmacology 2022; 13: 1015338
106370 Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Zagzoog A; Hurst DP
Frontiers in pharmacology 2022; 13: 919605
105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Wang X
Frontiers in pharmacology 2022; 13: 990401
106370 Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Stevenson LA
Frontiers in pharmacology 2022; 13: 919605
105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Zhu Y
Frontiers in pharmacology 2022; 13: 990401
106370 Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Pertwee RG; Imler GH; Reggio PH; Thakur GA; Laprairie RB
Frontiers in pharmacology 2022; 13: 919605
